Towards Healthcare
Glycobiology Market Size Grows 14.91% CAGR till 2034

Glycobiology Market Trends 2025 to 2034 Precision Medicine, Biomarker Discovery, and Valuation

Based on market forecasts, the global glycobiology market, projected at USD 0.65 billion in 2024, is expected to reach USD 2.63 billion by 2034, growing at a CAGR of 14.91% over the forecast period. Increasing biomedical research activities and enhanced investments in R&D are fueling the global market growth. Whereas, North America dominated the market with robust biopharma R&D and sequencing centers.

  • Insight Code: 5909
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: July 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The glycobiology market is projected to reach USD 2.63 billion by 2034, growing at a CAGR of 14.91% from 2024 to 2034.

North America is currently leading the glycobiology market due to strong biopharma R&D and sequencing centers.

The glycobiology market includes five segments such as by product and service, by technology, by application, by end user, and by region.

Key trends include rising demand for drug discovery and personalized medicine, growth in awareness related to glycan-based therapeutics in cancer & autoimmune diseases, and innovation in analytical technologies.

The methods used for glycan analysis are isoelectric focusing (IEF) and polyacrylamide gel (PAGE) electrophoresis for intact glycoproteins, capillary electrophoresis (CE) for intact glycoproteins, mass spectrometry (MS) for glycopeptides and released glycans.

NIH, NIST, US FDA, NCBI, NCI, UKRI, DST, PIB